Increased expression of the novel molecule OX-2 is involved in prolongation murine renal allograft survival

Transplantation

Volumn 65, Issue 8, 1998, Pages 1106-1114

  Gorczynski, Reginald M ^a,b   Chen, Zhiqi ^a   Fu, Xin Ming ^a   Zeng, Hua ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; COMPLEMENTARY DNA;

ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ARTICLE; DNA DETERMINATION; GRAFT SURVIVAL; IMMUNOBLOTTING; IMMUNOREGULATION; KIDNEY TRANSPLANTATION; MOLECULAR CLONING; MOUSE; NONHUMAN; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, SURFACE; BASE SEQUENCE; BONE MARROW CELLS; CLONING, MOLECULAR; CYTOKINES; DENDRITIC CELLS; DNA PRIMERS; DNA, COMPLEMENTARY; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; IN SITU HYBRIDIZATION; ISOANTIGENS; KIDNEY TRANSPLANTATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PORTAL VEIN; RATS; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, NUCLEIC ACID; T-LYMPHOCYTES; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0032571844     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199804270-00016     Document Type: Article

References (57)

1. Gorczynski RM, Wojcik D. A role for non-specific (cyclosporin A) or specific (mAbs to ICAM-1, LFA-1 and interleukin-10) immunomodulation in the prolongation of skin allografts after antigen-specific pre-transplant immunization or transfusion. J Immunol 1994; 152: 2011.
2. Gorczynski RM, Chen Z, Chung S, et al. Prolongation of rat small bowel or renal allograft survival by pretransplant transfusion and/or by varying the route of allograft venous drainage. Transplantation 1994; 58: 816.2.
3. Gorczynski RM. Immunosuppression induced by hepatic portal venous immunization spares reactivity in IL-4 producing T lymphocytes. Immunol Lett 1992; 33: 67.
4. + T cells. Immunology 1994; 81: 27
5. Gorczynski RM, Cohen Z, Leung Y, Chen Z. Gamma delta TCR(+) hybridomas derived from mice preimmunized via the portal vein adoptively transfer increased skin allograft survival in vivo. J Immunol 1996; 157: 574.
6. Jenkins MK, Pardoll DM, Mizuguchi J, Chused TM, Schwartz RH. Molecular events in the induction of a nonresponsive state in interleukin-2 producing helper T-lymphocyte clones. Proc Natl Acad Sci USA 1987; 84: 5409.
7. Schwartz RH. A cell culture model for T lymphocyte clonal anergy. Science 1990; 48: 1349.
8. Weaver CT, Unanue ER. The costimulatory function of antigen-presenting cells. Immunol Today 1990; 11: 49.
9. Van Seventer GA, Shimizu Y, Shaw S. Roles of multiple accessory molecules in T-cell activation. Curr Opin Immunol 1991; 3: 294.
10. Lenschow DJ, Bluestone JA. T cell costimulation and in vivo tolerance. Curr Opin Immunol 1993; 5: 747.
11. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996; 14: 233.
12. Freeman GJ, Boussiotis VA, Anumanthan A, et al. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 1995; 2: 523.
13. Bluestone JA. Is CTLA-4 a master switch for peripheral T cell tolerance? J Immunol 1997; 158: 1989.
14. Grewal IS, Foellmer HG, Grewal KD, et al. Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science 1996; 273: 1864.
15. Hancock WW, Sayegh MH, Zheng XG, Peach R, Linsley PS, Turka LA. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. Proc Natl Acad Sci USA 1996; 93:1396.
16. Mosmann TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7: 145.
17. Kelso A. Th1 and Th2 subsets: paradigms lost? Immunol Today 1995; 16: 374.
18. + T cells in vivo: differential expression of IL-2 and IL-4 mRNA in recipients of cardiac allografts. J Immunol 1992; 148: 1308.
19. O'Garra A, Murphy K. T cell subsets in autoimmunity. Curr Opin Immunol 1993; 5: 880.
20. Mohler KM, Streilin JW. Lymphokine production by MLR-reactive reaction lymphocytes obtained from normal mice and mice rendered tolerant of class II MHC antigens. Transplantation 1989; 47: 625.
21. Teng YT, Gorczynski RM, Iwasaki S, Williams DB, Hozumi N. Evidence for Th2 cell-mediated suppression of antibody responses in transgenic, beef insulin-tolerant mice. Eur J Immunol 1995; 25: 2522.
22. Staats HF, Jackson RJ, Marinaro M, Takahashi I, Kiyono H, McGhee JR. Mucosal immunity to infection with implications for vaccine development. Curr Opin Immunol 1994; 6: 572.
23. Dallman MJ. Cytokines as mediators of organ graft rejection and tolerance. Curr Opin Immunol 1993; 5: 789.
24. Gorczynski RM, Hozumi N, Wolfe SW, Chen Z. IL-12 reverses graft prolongation following portal venous immunization. Transplantation 1995; 60: 1337.
25. Carter LL, Dutton RW. Type 1 and type 2: a fundamental dichotomy for all T-cell subsets. Curr Opin Immunol 1996; 8: 336.
26. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon γ-production by suppressing natural killer stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 1993; 178: 1041.
27. Manetti, R, Gerosa F, Giudizi MG, et al. Interleukin 12 induces stable priming for interferon γ (IFNγ) production during differentiation of human T helper (Th) cells and transient IFNγ production in established Th2 cell clones. J Exp Med 1994; 179: 1273.
28. Skeen MJ, Miller MA, Shinnick TM, Ziegler HK. Regulation of murine macrophage IL-12 production: activation of macrophages in vivo, restimulation in vitro, and modulation by other cytokines. J Immunol 1996; 156: 1196.
29. Gorczynski RM, Holmes W. Specific manipulation of immunity to skin grafts bearing multiple minor histocompatibility differences. Immunol Lett 1991; 27: 163.
30. Gorczynski RM. Regulation of IFNγ and IL-10 synthesis in vivo, as well as continuous antigen exposure, is associated with tolerance to murine skin allografts. Cell Immunol 1995; 160: 224.
31. Miller A, Al-Sabbagh A, Santos LMB, Das MP, Weiner HL. Epitopes of myelin basic protein that trigger TGF-β release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression. J Immunol 1993; 151: 7307.
32. Nickerson P, Steurer W, Steiger J, Zheng X, Steele AW, Strom TB. Cytokines and the Th1/Th2 paradigm in transplantation. Curr Opin Immunol 1994; 6: 757.
33. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993; 75: 253.
34. Hendrick SM, Cohen DI, Nielsen EL, Davis MM. Isolation of cDNA clones encoding T cell-specific membrane-associated proteins. Nature 1984; 308: 149.
35. Sargent TL, Dawid IB. Differential gene expression in the gastrula of Xenopus laevis. Science 1983; 222: 135.
36. Hara E, Kato T, Nakada S, Sekiya L, Oda K. Subtractive cDNA cloning using oligo (dT)30-latex and PCR: isolation of cDNA clones specific to undifferentiated human embryonal carcinoma cells. Nucleic Acids Res 1991; 19: 7097.
37. Hubank M, Schatz DG. Identifying differences in MRNA expression by representational difference analysis of cDNA. Nucleic Acids Res 1994; 22: 5640.
38. Bauer D, Warthoe P, Rhode L, Struss M. Detection and differential display of expressed genes by DDRT-PCR. In: PCR methods and applications. Plainview, NY: Cold Spring Harbor Laboratory Press, 1994: (suppl 97) 97.
39. Diatchenko L, Lau YFC, Campbell AP, et al. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci USA 1996; 93: 1.
40. Borriello F, Lederer J, Scott S, Sharpe AH. MRC OX-2 defines a novel T cell costimulatory pathway. J Immunol 1997; 158: 4548.
41. Chen Z, Gorczynski RM. Cloning and characterization of the murine homologue of the rat/human MRC OX-2 gene. Biochim Biophys Acta 1997; 1362: 6.
42. Gorczynski RM, Cohen Z, Fu XM, Hua Z, Sun YL, Chen Z. Interleukin-13, in combination with anti-interleukin-12, increases graft prolongation after portal venous immunization with cultured allogeneic bone marrow-derived dendritic cells. Transplantation 1996; 62: 1592.
43. Sandhu GS, Eckloff BW, Kline BC. Chemiluminescent substrates increase sensitivity of antigen detection in Western blots. Biotechniques 1991; 11: 14.
44. Bronstein I, Voyta JC, Murphy OJ, Bresnick L, Kricka LJ. Improved chemiluminescence Western blotting procedure. Biotechniques 1992; 12: 748.
45. Britten RL, Davidson EH. Nucleic acids hybridization: a practical approach. Hames BD, Higgins SJ (eds). Oxford: IRL, 1985: 3.
46. Barclay AN. Different reticular elements in rat lymphoid tissue identified by localization of Ia, Thy-1 and MRC OX-2 antigens. Immunology 1981; 44: 727.
47. Barclay AN, Ward HA. Purification and chemical characterization of membrane glycoproteins from rat thymocytes and brain, recognized by monoclonal anrtibody MRC OX-2. Eur J Biochem 1982; 129: 447.
48. Flye MW, Burton K, Mohanakumar T, et al. Donor-specific transfusions have long-term beneficial effects for human renal allografts. Transplantation 1995; 60: 1395.
49. Yoshimura N, Matsui S, Hamashima T, Lee CJ, Ohsaka Y, Oka T. The effects of perioperative portal venous inoculation with donor lymphocytes on renal allograft survival in the rat. I. Specific prolongation of donor grafts and suppressor factor in the serum. Transplantation 1990; 49: 167.
50. Kamei T, Callery MP, Flye MW. Pretransplant portal venous administration of donor antigen and portal venous allograft drainage synergistically prolong rat cardiac allograft survival. Surgery 1990; 108: 415.
51. Gorczynski RM, Kiziroglu F. Role of CTLA4-Ig on induction of unresponsiveness to multiple minor alloantigens. Transpl Int 1994; 7 (suppl 1): 599.
52. Castle BE, Kishimoto K, Stearns C, Brown ML, Kehry MR. Regulation of the expression of the ligand for CD40 on T helper lymphocytes. J Immunol 1993; 151: 1777.
53. Larsen CP, Ritchie SC, Hendrix R, et al. Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells. J Immunol 1994; 152: 5208.
54. Vidard L, Rock KL, Benacerraf B. Heterogeneity in antigen processing by different types of antigen-presenting cells: effect of cell culture on antigen processing ability. J Immunol 1992; 149: 1905.
55. Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricardi C. Cell migration, chimaerism and graft acceptance. Lancet 1992; 339: 1579.
56. Kawamura T, Furue M. Comparative analysis of B7-1 and B7-2 expression in Langerhans cells: differential regulation by T helper type 1 and T helper type 2 cytokines. Eur J Immunol 1995; 25: 1913.
57. Preston S, Wright GJ, Barclay AN, Brown MH. The leukocyte/ neuron cell surface antigen OX2 binds to a ligand on macrophages. Eur J Immunol 1997; 27: 1911.